We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer

    Apocrine carcinoma is a rare breast cancer subtype. As such, the genomic characteristics of apocrine carcinoma with triple negative...

    Ji-Yeon Kim, Sabin Park, ... Young-Hyuck Im in Experimental & Molecular Medicine
    Article Open access 03 July 2023
  2. The cross-talk of cancer-associated fibroblasts assist in prognosis and immunotherapy in patients with breast carcinoma

    The association between cancer-associated fibroblasts (CAFs) and tumor microenvironment (TME) is a key factor in promoting tumor progression....

    Xuyu Gu, Shiya Zheng, ... Qin Zhou in Cancer Gene Therapy
    Article 10 August 2022
  3. Effect of histological breast cancer subtypes invasive lobular versus non-special type on survival in early intermediate-to-high-risk breast carcinoma: results from the SUCCESS trials

    Background

    Invasive lobular breast carcinomas (ILC) have different histological features compared to non-special type carcinomas (NST), but the effect...

    Davut Dayan, Stefan Lukac, ... Thomas W. P. Friedl in Breast Cancer Research
    Article Open access 14 December 2023
  4. Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial)

    Background

    Radiotherapy (RT) following breast-conserving surgery (BCS) is mainly used to decrease the rate of ipsilateral breast tumor recurrence...

    Sung-Hsin Kuo, Ling-Ming Tseng, ... Chiun-Sheng Huang in BMC Cancer
    Article Open access 14 September 2023
  5. Breast Cancer

    Breast cancer is currently the most diagnosed cancer in the female population, with a prevalence of 1 in 8 women.
    Emilia Marrazzo, Chiara Annunziata Pasqualina Anghelone, Elena Vittoria Longhi in Managing Psychosexual Consequences in Chronic Diseases
    Chapter 2023
  6. Pilot Experiment on Non-Invasive Non-Thermal Disintegration of Human Mucinous Breast Carcinoma Ex Vivo Using Boiling Histotripsy

    We present the results of a pilot study demonstrating the feasibility of non-invasive non-thermal disintegration of human mucinous carcinoma of the...

    E. M. Ponomarchuk, S. A. Tsysar, ... V. A. Khokhlova in Bulletin of Experimental Biology and Medicine
    Article 04 July 2024
  7. Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer

    Background

    Risk of recurrence and progression of ductal carcinoma in situ (DCIS) to invasive cancer remains uncertain, emphasizing the need for...

    Warapen Treekitkarnmongkol, Vandna Shah, ... Subrata Sen in British Journal of Cancer
    Article 17 May 2024
  8. Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma

    Background

    Metaplastic breast carcinoma (MpBC) typically consists of carcinoma of no special type (NST) with various metaplastic components. Although...

    Huang-Chun Lien, Chia-Lang Hsu, ... Ching-Hung Lin in Breast Cancer Research
    Article Open access 27 January 2023
  9. Unveiling innovative therapeutic strategies and future trajectories on stimuli-responsive drug delivery systems for targeted treatment of breast carcinoma

    This comprehensive review delineates the latest advancements in stimuli-responsive drug delivery systems engineered for the targeted treatment of...

    Israa Habeeb Naser, Muhaned Zaid, ... Ali Alsalamy in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 14 December 2023
  10. Cell Cycle Dysregulation in Breast Cancer

    Cancer, a condition characterized by abnormal cell growth, is closely linked to the cell cycle. In reaction to mitogenic cues, all malignancies...
    Manzoor Ahmad Mir, Sameer Ullah Khan, Shariqa Aisha in Therapeutic potential of Cell Cycle Kinases in Breast Cancer
    Chapter 2023
  11. Introduction to Breast Cancer

    Breast cancer is the leading cause of mortality among women worldwide. Being a heterogenous disease it comprises many different subtypes that differ...
    Chapter 2023
  12. Hardware deployment of deep learning model for classification of breast carcinoma from digital mammogram images

    Cancer is an illness that instils fear in many individuals throughout the world due to its lethal nature. However, in most situations, cancer may be...

    Kayalvizhi R, Heartlin Maria H, ... Shantanu Patil in Medical & Biological Engineering & Computing
    Article 26 July 2023
  13. Gallium maltolate shows synergism with cisplatin and activates nucleolar stress and ferroptosis in human breast carcinoma cells

    Purpose

    Breast cancer is the most common cancer in women. Triple-negative breast cancer (TNBC) is an aggressive disease with poor outcomes. TNBC lacks...

    Chieh-Hsin Chen, Yi-Ming Huang, ... Kai-Yin Lo in Cellular Oncology
    Article 17 April 2023
  14. Vangl-dependent Wnt/planar cell polarity signaling mediates collective breast carcinoma motility and distant metastasis

    Background

    In light of the growing appreciation for the role of collective cell motility in metastasis, a deeper understanding of the underlying...

    Kacey VanderVorst, Courtney A. Dreyer, ... Kermit L. Carraway III in Breast Cancer Research
    Article Open access 05 May 2023
  15. Association of hormone receptors and human epidermal growth factor receptor-2/neu expressions with clinicopathologic factors of breast carcinoma: a cross-sectional study in a tertiary care hospital, Kabul, Afghanistan

    Background

    Breast cancer (BC) is one of the major causes of death worldwide. It is the most common cause of death before the age of 70 years. The...

    Esmatullah Esmat, Ahmed Maseh Haidary, ... Jamshid Abdul-Ghafar in BMC Cancer
    Article Open access 27 March 2024
  16. Molecular Profiling and Personalized Medicine in Drug-Resistant Breast Cancer

    The utilization of molecular profiling techniques and personalized medicine approaches in the management of breast cancer is driven by molecular...
    Lloyd Mabonga, Aristotelis Chatziioannou, Zodwa Dlamini in Overcoming Breast Cancer Therapy Resistance
    Chapter 2024
  17. Breast Cancer: Epidemiology, Types, Diagnosis, and Treatment

    Breast cancer is a complex disease, and many aspects of this disease are under intensive research. Better treatment of breast cancer can only be...
    Madhumita Roy, Jaydip Biswas, Amitava Datta in Genetics and Epigenetics of Breast Cancer
    Chapter 2023
  18. Markers associated with genomic instability, immunogenicity and immune therapy responsiveness in Metaplastic carcinoma of the breast: Expression of γH2AX, pRPA2, P53, PD-L1 and tumor infiltrating lymphocytes in 76 cases

    Background

    Metaplastic breast cancer (MpBC) is an aggressive subtype of breast carcinoma that is often resistant to conventional chemotherapy....

    S. Voutilainen, P. Heikkilä, ... J. Mattson in BMC Cancer
    Article Open access 12 December 2022
  19. Mixed invasive ductal lobular carcinoma is clinically and pathologically more similar to invasive lobular than ductal carcinoma

    Background

    Mixed invasive ductal lobular carcinoma (mDLC) remains a poorly understood subtype of breast cancer composed of coexisting ductal and...

    Azadeh Nasrazadani, Yujia Li, ... Norman Wolmark in British Journal of Cancer
    Article 05 January 2023
  20. Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma

    Metaplastic breast carcinoma (MpBC) is a rare special histologic subtype of breast carcinoma characterized by the presence of squamous and/or...

    Willard Wong, Edi Brogi, ... Hannah Y. Wen in npj Breast Cancer
    Article Open access 22 July 2021
Did you find what you were looking for? Share feedback.